We previously demonstrated that Rac1 increased cyclin D1 promoter activity
in an extracellular signal-regulated kinase (ERK)-independent, antioxidant-
sensitive manner. Here, we examined the regulation of cyclin D1 expression
by Cdc42 and RhoA. Overexpression of active Cdc42, but not of RhoA, induced
transcription from the cyclin D1 promoter. Furthermore, dominant negative
Cdc42, but not RhoA, attenuated platelet-derived growth factor-mediated act
ivation of the cyclin D1 promoter. Overexpression of active Cdc42 increased
cyclin D1 protein abundance in COS cells. Cdc42-induced cyclin D1 promoter
activation was independent of ERK as evidenced by insensitivity to PD-9805
9, an inhibitor of mitogen-activated protein kinase/ERK kinase (MEK). Furth
ermore, Cdc42 was neither sufficient nor required for activation of ERK. Si
milar to Rac1-induced cyclin D1 expression, pretreatment with the antioxida
nts catalase and ebselen inhibited Cdc42-mediated transcription from the cy
clin D1 promoter. Finally, like Rac1, active Cdc42 induced transactivation
of the cyclin D1 promoter cAMP response element binding protein/activating
transcription factor-2 binding site. Together, these data suggest that in a
irway smooth muscle cells, Cdc42 and Rac1 share a common signaling pathway
to cyclin D1 promoter activation.